IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,558,900 | -67.1% | 1,390,000 | -62.4% | 0.40% | -69.4% |
| Q4 2022 | $65,563,530 | +118.7% | 3,693,720 | -31.2% | 1.29% | +119.2% |
| Q3 2022 | $29,979,000 | +43.1% | 5,372,512 | 0.0% | 0.59% | +31.7% |
| Q2 2022 | $20,953,000 | -29.2% | 5,372,512 | 0.0% | 0.45% | -3.4% |
| Q1 2022 | $29,603,000 | -29.8% | 5,372,512 | +8.5% | 0.46% | -13.9% |
| Q4 2021 | $42,174,000 | -2.0% | 4,950,000 | 0.0% | 0.54% | -4.9% |
| Q3 2021 | $43,016,000 | +20.7% | 4,950,000 | +46.8% | 0.57% | +18.4% |
| Q2 2021 | $35,631,000 | -10.2% | 3,370,994 | +36.3% | 0.48% | -18.5% |
| Q1 2021 | $39,667,000 | -7.9% | 2,473,000 | +165.3% | 0.59% | -10.9% |
| Q4 2020 | $43,049,000 | +31.3% | 932,000 | 0.0% | 0.66% | +2.8% |
| Q3 2020 | $32,797,000 | +115.2% | 932,000 | +48.9% | 0.64% | +94.0% |
| Q2 2020 | $15,242,000 | – | 625,950 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |